Overview

Comparison of Trelstar Versus Lupron or Zoladex in Advanced Prostate Cancer

Status:
Terminated
Trial end date:
2006-07-01
Target enrollment:
Participant gender:
Summary
This research study looks at Testosterone levels in patients receiving Trelstar versus those receiving Lupron or Zoladex. These drugs have been approved for treatment of Prostate Cancer by the FDA.
Phase:
Phase 4
Details
Lead Sponsor:
Pharmatech
Collaborators:
Manyak, Michael, M.D.
Watson Pharmaceuticals
Treatments:
Goserelin
Leuprolide
Triptorelin Pamoate